<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24901701</article-id><article-id pub-id-type="pmc">4071583</article-id><article-id pub-id-type="doi">10.3390/md12063399</article-id><article-id pub-id-type="publisher-id">marinedrugs-12-03399</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Potent Cytotoxic Peptides from the Australian Marine Sponge <italic>Pipestela candelabra</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tran</surname><given-names>Trong D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pham</surname><given-names>Ngoc B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fechner</surname><given-names>Gregory A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hooper</surname><given-names>John N. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Quinn</surname><given-names>Ronald J.</given-names></name><xref rid="c1-marinedrugs-12-03399" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-marinedrugs-12-03399">Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland 4111, Australia; E-Mails: <email>trong.tran@griffithuni.edu.au</email> (T.D.T.); <email>n.pham@griffith.edu.au</email> (N.B.P.); <email>gregfeq@gmail.com</email> (G.A.F.); <email>john.hooper@qm.qld.gov.au</email> (J.N.A.H.)</aff><author-notes><corresp id="c1-marinedrugs-12-03399"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>r.quinn@griffith.edu.au</email>; Tel.: +61-7-3735-6009; Fax: +61-7-3735-6001.</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2014</year></pub-date><volume>12</volume><issue>6</issue><fpage>3399</fpage><lpage>3415</lpage><history><date date-type="received"><day>04</day><month>3</month><year>2014</year></date><date date-type="rev-recd"><day>10</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2014</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Two consecutive prefractionated fractions of the Australian marine sponge extract, <italic>Pipestela candelabra</italic>, were identified to be selectively active on the human prostate cancer cells (PC3) compared to the human neonatal foreskin fibroblast non-cancer cells (NFF). Twelve secondary metabolites were isolated in which four compounds are new small peptides. Their structures were characterized by spectroscopic and chemical analysis. These compounds inhibited selectively the growth of prostate cancer cells with IC<sub>50</sub> values in the picomolar to sub-micromolar range. Structure-activity relationship of these compounds is discussed.</p></abstract><kwd-group><kwd><italic>Pipestela candelabra</italic></kwd><kwd>cytotoxicity</kwd><kwd>peptide</kwd><kwd>milnamide</kwd><kwd>hemiasterlin</kwd><kwd>geodiamolide</kwd><kwd>prostate cancer</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p><italic>Pipestela</italic> has been characterized as a new sponge genus sharing some shape features and molecular DNA sequences with ten other genera in the family Axinellidae: <italic>Auletta</italic>, <italic>Axinella</italic>, <italic>Cymbastela</italic>, <italic>Dragmacidon</italic>, <italic>Dragmaxia</italic>, <italic>Pararhaphoxya</italic>, <italic>Phakellia</italic>, <italic>Phycopsis</italic>, <italic>Ptilocaulis</italic>, and <italic>Reniochalina</italic> [<xref rid="B1-marinedrugs-12-03399" ref-type="bibr">1</xref>]. The genus <italic>Pipestela</italic> is distributed only across the north-eastern region of Australia, and is very common from the Great Barrier Reef, Coral Sea, Papua New Guinea, Solomon Islands, and Vanuatu [<xref rid="B2-marinedrugs-12-03399" ref-type="bibr">2</xref>]. Chemical investigation of the sponge <italic>P</italic>. <italic>candelabra</italic> was first reported in 2012 with the identification of four cyclodepsipeptides, including jaspamide and pipestelides A&#x02013;C, from a sample collected in the Solomon Islands [<xref rid="B3-marinedrugs-12-03399" ref-type="bibr">3</xref>]. However, a different structure class, hemiasterlin and milnamide analogues, was found in this chemical study on the Australian sponge <italic>P</italic>. <italic>candelabra</italic>.</p><p>Hemiasterlins and milnamides are two related small cytotoxic peptide families from marine sponges. Their structural features contain a dipeptide side chain of two unnatural amino acid residues, <italic>tert</italic>-leucine and <italic>N</italic>-methylvinylogous valine. This dipeptide fragment is incorporated with another atypical amino acid residue tri- or tetra-methylated tryptophan to produce the hemiasterlins or connected to a tetrahydro-&#x003b2;-carboline residue to form the milnamides. So far, six hemiasterlin derivatives (hemiasterlin or milnamide B [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>], hemiasterlin A [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>], hemiasterlin B [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>], hemiasterlin C [<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>], crinamide A [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>] and crinamide B [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>]), and three milnamide analogues (milnamide A [<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>], milnamide C [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>] and milnamide D [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>]) have been identified from four sponge genera including <italic>Auletta</italic> [<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>], <italic>Cymbastela</italic> [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], <italic>Hemiasterella</italic> [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>], and <italic>Siphonochalina</italic> [<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>]. These related natural products show potent cytotoxicity against many cancer cell lines, such as murine leukemia P388, human breast cancer MCF7, human glioblastoma/astrocytoma U373, human ovarian cancer HEY, human colon cancers LOVO and HT-29, human lung cancer A549, and murine melanoma B16-F10 [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>]. In addition, hemiasterlin was a more potent <italic>in vitro</italic> cytotoxin and antimitotic agent than either of the anticancer drugs taxol or vincristine [<xref rid="B10-marinedrugs-12-03399" ref-type="bibr">10</xref>]. This made it stand out as an extremely exciting natural product lead structure for an anticancer drug development program. Many synthetic methodologies have been developed to produce a large number of hemiasterlin analogues [<xref rid="B10-marinedrugs-12-03399" ref-type="bibr">10</xref>,<xref rid="B11-marinedrugs-12-03399" ref-type="bibr">11</xref>,<xref rid="B12-marinedrugs-12-03399" ref-type="bibr">12</xref>,<xref rid="B13-marinedrugs-12-03399" ref-type="bibr">13</xref>]. From structure-activity relationship studies, the <italic>tert</italic>-leucine and <italic>N</italic>-methylvinylogous valine residues were found to be essential for bioactivity [<xref rid="B10-marinedrugs-12-03399" ref-type="bibr">10</xref>]. In 2003, the first hemiasterlin analogue HTI-286 (<bold>13</bold>) was selected for evaluation in a phase I clinical trial in patients with advanced solid tumors [<xref rid="B10-marinedrugs-12-03399" ref-type="bibr">10</xref>,<xref rid="B14-marinedrugs-12-03399" ref-type="bibr">14</xref>]. A phase II trial of HTI-286 has been halted since there were no objective responses and common toxicities observed included neutropaenia, nausea, alopecia, and pain [<xref rid="B15-marinedrugs-12-03399" ref-type="bibr">15</xref>]. However, there remains a particular interest to develop and examine the therapeutic effect of novel hemiasterlin derivatives. In 2009, another hemiasterlin analogue E7974 (<bold>14</bold>) with the <italic>N</italic>-isopropyl-<sc>d</sc>-pipecolic acid substituent replacing the <italic>N</italic>-methyltryptophan residue showed strong <italic>in vivo</italic> antitumor efficacy in many human xenograft cancer models and overcame a second mechanism of drug resistance present in cancer cells [<xref rid="B16-marinedrugs-12-03399" ref-type="bibr">16</xref>]. Results from phase I clinical trial have recently revealed that the compound E7974 remains a promising candidate for the treatment of several forms of advanced solid tumors in colorectal, pancreatic and liposarcoma cancer patients [<xref rid="B17-marinedrugs-12-03399" ref-type="bibr">17</xref>]. Human clinical testing of E7974 is currently ongoing [<xref rid="B17-marinedrugs-12-03399" ref-type="bibr">17</xref>].</p><p>In the search for potential antitumor compounds from marine organisms, a subset of fractions in our Nature Bank prefractionated natural product library [<xref rid="B18-marinedrugs-12-03399" ref-type="bibr">18</xref>] was screened in cell-based cytotoxicity assays. Two consecutive fractions derived from the Australian sponge <italic>Pipestela candelabra</italic> were identified with a selective activity on the PC3 cancer cells compared to the NFF noncancer cells. This paper outlines the isolation, structure elucidation of four new compounds, milnamides E&#x02013;G (<bold>1</bold>&#x02013;<bold>3</bold>) and hemiasterlin D (<bold>4</bold>), along with eight known compounds including milnamide A (<bold>5</bold>) [<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], milnamide C (<bold>6</bold>) [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>], milnamide D (<bold>7</bold>) [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], hemiasterlin (or milnamide B) (<bold>8</bold>) [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>,<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>,<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], hemiasterlin A (<bold>9</bold>) [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>], geodiamolide D (<bold>10</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>], geodiamolide E (<bold>11</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>], and geodiamolide F (<bold>12</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>] from two collections of the Australian sponge <italic>P</italic>. <italic>candelabra</italic> (<xref ref-type="fig" rid="marinedrugs-12-03399-f001">Figure 1</xref>). Although hemiasterlins, milnamides and geodiamolides have been found co-occurring in <italic>Hemiasterella minor</italic> [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>], <italic>Cymbastela</italic> sp. [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>] and <italic>Auletta</italic> sp. [<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>], this is the first report of them from the sponge <italic>Pipestela candelabra</italic>.</p><fig id="marinedrugs-12-03399-f001" position="float"><label>Figure 1</label><caption><p>Chemical structures of compounds isolated from the Australian sponge <italic>P</italic>. <italic>candelabra</italic> (<bold>A</bold>) and related-hemiasterlin anticancer agents in clinical trial (<bold>B</bold>).</p></caption><graphic xlink:href="marinedrugs-12-03399-g001"/></fig></sec><sec><title>2. Results and Discussion</title><p>Compound <bold>1</bold> was obtained as a white amorphous solid. The (+)-HRESIMS displayed a pseudomolecular ion peak [M + H]<sup>+</sup> ([C<sub>30</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>]<sup>+</sup>) at <italic>m/z</italic> 525.3418, which was consistent with the molecular formula C<sub>30</sub>H<sub>44</sub>N<sub>4</sub>O<sub>4</sub>. Compound <bold>1</bold> was first isolated as a trifluoroacetic acid (TFA) salt and had broad signals in the <sup>1</sup>H nuclear magnetic resonance (NMR) spectrum. Better NMR resolution was obtained after converting this compound from its TFA salt to formic acid (FA) salt. Combined data from <sup>13</sup>C NMR and gHSQCAD spectra (<xref ref-type="table" rid="marinedrugs-12-03399-t001">Table 1</xref>) revealed three carbonyls (&#x003b4;<sub>C</sub> 171.0, 169.7, and 168.6 ppm), 10 aromatic and olefinic carbons (&#x003b4;<sub>C</sub> 138.2, 135.9, 131.8, 131.7, 125.4, 119.5, 118.6, 117.9, 113.0, and 110.9 ppm), two <italic>N</italic>-methyl carbons (&#x003b4;<sub>C</sub> 43.0 and 30.8 ppm), and 15 methine and methyl carbons (&#x003b4;<sub>C</sub> 72.1, 55.8, 53.4, 48.6, 34.7, 34.3, 30.0, 28.8, 3 &#x000d7; 26.4, 24.1, 19.3, 18.8, and 13.5 ppm). An indole ring system was deduced based on an ABCD spin system with signals at &#x003b4;<sub>H</sub> 7.47 (H-5, d, <italic>J</italic> = 8.4 Hz), 6.87 (H-6, t, <italic>J</italic> = 7.2, 7.8 Hz), 6.95 (H-7, t, <italic>J</italic> = 7.2, 7.8 Hz), and 7.24 (H-8, d, <italic>J</italic> = 8.4 Hz), an exchangeable proton NH (H-9) at &#x003b4;<sub>H</sub> 10.62 ppm and HMBC correlations from H-5 to C-4a (&#x003b4;<sub>C</sub> 113.0 ppm), from H-6 to C-4b (&#x003b4;<sub>C</sub> 125.4 ppm), from H-7 to C-8a (&#x003b4;<sub>C</sub> 135.9 ppm) and from the NH signal to C-4a, C-4b, C-8a and C-9a (&#x003b4;<sub>C</sub> 131.8 ppm). Further HMBC analysis indicated the correlations from H-1 (&#x003b4;<sub>H</sub> 3.62/3.88 ppm) to C-3 (&#x003b4;<sub>C</sub> 72.1 ppm), C-4a, C-9a and an C-19 (&#x003b4;<sub>C</sub> 43.0 ppm), and from H-3 to C-1 (&#x003b4;<sub>C</sub> 48.6 ppm), C-4 (&#x003b4;<sub>C</sub> 34.7 ppm), C-4a, C-10 (&#x003b4;<sub>C</sub> 169.7 ppm), C-19, C-20 (&#x003b4;<sub>C</sub> 30.0 ppm) and C-20&#x02032; (&#x003b4;<sub>C</sub> 24.1 ppm) supporting the establishment of a 2,4,4-trimethyl-2,3,4,9-tetrahydro-1<italic>H</italic>-&#x003b2;-carboline moiety (<bold>ttbc</bold>, <xref ref-type="fig" rid="marinedrugs-12-03399-f002">Figure 2</xref>). ROESY correlations from NH (&#x003b4;<sub>H</sub> 10.62 ppm) to both H-1 and H-8 further confirmed this assignment. A doublet proton at &#x003b4;<sub>H</sub> 4.75 ppm (H-12) showed a COSY correlation with an exchangeable proton H-11 (&#x003b4;<sub>H</sub> 7.90 ppm) and HMBC correlations to C-12a (&#x003b4;<sub>C</sub> 34.3 ppm), C-13 (&#x003b4;<sub>C</sub> 171.0 ppm), and C-22 (&#x003b4;<sub>C</sub> 26.4 ppm). A tert-butyl group was assigned based on a HMBC correlation from a signal of three equivalent methyls (H-22, &#x003b4;<sub>H</sub> 0.90 ppm) to C-12a. These <italic>tert</italic>-butyl protons also showed a HMBC correlation with a methine carbon C-12 at &#x003b4;<sub>C</sub> 53.4 ppm indicating the presence of a <italic>tert</italic>-leucine residue (<bold><italic>tert</italic>-Leu</bold>, <xref ref-type="fig" rid="marinedrugs-12-03399-f002">Figure 2</xref>). A spin system =CH-CH-CH-(CH<sub>3</sub>)<sub>2</sub> was deduced due to COSY correlations from H-16 (&#x003b4;<sub>H</sub> 6.59 ppm) to H-15 (&#x003b4;<sub>H</sub> 4.89 ppm); from H-15a (&#x003b4;<sub>H</sub> 1.91 ppm) to both H-15 and two methyl groups H-24 (&#x003b4;<sub>H</sub> 0.77 ppm) and H-24&#x02032; (&#x003b4;<sub>H</sub> 0.67 ppm). HMBC correlations from H-15 to an <italic>N</italic>-methyl C-23 (&#x003b4;<sub>C</sub> 30.8 ppm), H-16 to C-18 (&#x003b4;<sub>C</sub> 168.6 ppm) and C-25 (&#x003b4;<sub>C</sub> 13.5 ppm) and also from H-25 (&#x003b4;<sub>H</sub> 0.67 ppm) to C-16, C-17 (&#x003b4;<sub>C</sub> 131.7 ppm) and C-18 suggested the presence of an <italic>N</italic>-methylvinylogous valine residue (<bold>mvv</bold>, <xref ref-type="fig" rid="marinedrugs-12-03399-f002">Figure 2</xref>). The <italic>E</italic>-configuration was assigned to &#x02206;<sup>16&#x02212;17</sup> according to the distinctively upfield chemical shift of C-25 at &#x003b4;<sub>H</sub> 13&#x02013;14 ppm (rather than at 22&#x02013;25 ppm for the <italic>Z</italic>-configuration) [<xref rid="B21-marinedrugs-12-03399" ref-type="bibr">21</xref>,<xref rid="B22-marinedrugs-12-03399" ref-type="bibr">22</xref>,<xref rid="B23-marinedrugs-12-03399" ref-type="bibr">23</xref>]. HMBC correlations from H-12 to C-10, from H-23 to C-13 and ROESY correlations between H-3 and H-11 and also between H-12 and H-23 supported the connection of moieties <bold>ttbc</bold>-<bold><italic>tert</italic>-Leu</bold>-<bold>mvv</bold> (<xref ref-type="fig" rid="marinedrugs-12-03399-f002">Figure 2</xref>). A planar structure of a new milnamide derivative, named milnamide E, was established.</p><fig id="marinedrugs-12-03399-f002" position="float"><label>Figure 2</label><caption><p>Partial structures (in bold) and key HMBC and ROESY correlations of <bold>1</bold>.</p></caption><graphic xlink:href="marinedrugs-12-03399-g002"/></fig><table-wrap id="marinedrugs-12-03399-t001" position="float"><object-id pub-id-type="pii">marinedrugs-12-03399-t001_Table 1</object-id><label>Table 1</label><caption><p>NMR data for milnamides E, F, and G (<bold>1</bold>&#x02013;<bold>3</bold>) recorded in DMSO-<italic>d<sub>6</sub></italic>
<sup>a</sup> at 30 &#x000b0;C.</p></caption><table frame="hsides" rules="rows"><thead><tr><th rowspan="2" colspan="2" align="center" valign="middle">Position</th><th colspan="8" align="center" valign="middle" rowspan="1">1 <sup>a</sup></th><th colspan="8" align="center" valign="middle" rowspan="1">2 <sup>b</sup></th><th colspan="5" align="center" valign="middle" rowspan="1">3 <sup>b</sup></th></tr><tr><th colspan="2" align="center" valign="middle" rowspan="1">&#x003b4;<sub>C</sub>
<sup>e</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">&#x003b4;<sub>H</sub> (<italic>J</italic> in Hz) <sup>e</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">ROESY <sup>e</sup></th><th colspan="3" align="center" valign="middle" rowspan="1">gHMBCAD <sup>e</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">&#x003b4;<sub>C</sub>
<sup>e,f</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">&#x003b4;<sub>H</sub> (<italic>J</italic> in Hz) <sup>e</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">ROESY <sup>e</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">gHMBCAD <sup>e</sup></th><th colspan="2" align="center" valign="middle" rowspan="1">&#x003b4;<sub>C</sub>
<sup>e</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;<sub>H</sub> (<italic>J</italic> in Hz) <sup>e</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">ROESY <sup>e</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">gHMBCAD <sup>e</sup></th></tr></thead><tbody><tr><td colspan="2" align="center" valign="middle" rowspan="1">1</td><td colspan="2" align="center" valign="middle" rowspan="1">48.6</td><td colspan="2" align="center" valign="middle" rowspan="1">3.62, d (14.4)<break/>3.88, d (14.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">9<break/>19</td><td colspan="3" align="center" valign="middle" rowspan="1">3, 4a, 9a<break/>3, 4a, 9a, 19</td><td colspan="2" align="center" valign="middle" rowspan="1">160.9</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">156.8</td><td align="center" valign="middle" rowspan="1" colspan="1">9.14, s</td><td align="center" valign="middle" rowspan="1" colspan="1">9, 19</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4a, 9a, 19</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">3</td><td colspan="2" align="center" valign="middle" rowspan="1">72.1</td><td colspan="2" align="center" valign="middle" rowspan="1">3.40, s</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 19, 20, 20&#x02032;</td><td colspan="3" align="center" valign="middle" rowspan="1">1, 4, 4a, 10, 19, 20</td><td colspan="2" align="center" valign="middle" rowspan="1">72.5</td><td colspan="2" align="center" valign="middle" rowspan="1">4.26, s</td><td colspan="2" align="center" valign="middle" rowspan="1">11, 19, 20, 20&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">1, 4, 4a, 10, 19, 20</td><td colspan="2" align="center" valign="middle" rowspan="1">72.2</td><td align="center" valign="middle" rowspan="1" colspan="1">4.80, s</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 19, 20, 20&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 4, 4a, 10, 19, 20</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">4</td><td colspan="2" align="center" valign="middle" rowspan="1">34.7</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">35.1</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">36.6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">4a</td><td colspan="2" align="center" valign="middle" rowspan="1">113.0</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">121.9</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">128.8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">4b</td><td colspan="2" align="center" valign="middle" rowspan="1">125.4</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">123.8</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">122.6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">5</td><td colspan="2" align="center" valign="middle" rowspan="1">118.6</td><td colspan="2" align="center" valign="middle" rowspan="1">7.47, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">20&#x02032;</td><td colspan="3" align="center" valign="middle" rowspan="1">4a, 4b, 7, 8a</td><td colspan="2" align="center" valign="middle" rowspan="1">120.3</td><td colspan="2" align="center" valign="middle" rowspan="1">7.61, d (7.8)</td><td colspan="2" align="center" valign="middle" rowspan="1">20&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">7, 8a</td><td colspan="2" align="center" valign="middle" rowspan="1">122.2</td><td align="center" valign="middle" rowspan="1" colspan="1">7.80, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">20&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">7, 8a</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">6</td><td colspan="2" align="center" valign="middle" rowspan="1">117.9</td><td colspan="2" align="center" valign="middle" rowspan="1">6.87, t (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">4b, 8</td><td colspan="2" align="center" valign="middle" rowspan="1">118.9</td><td colspan="2" align="center" valign="middle" rowspan="1">6.97, t (7.8)</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">4b</td><td colspan="2" align="center" valign="middle" rowspan="1">121.8</td><td align="center" valign="middle" rowspan="1" colspan="1">7.15, t (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4b, 8</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">7</td><td colspan="2" align="center" valign="middle" rowspan="1">119.5</td><td colspan="2" align="center" valign="middle" rowspan="1">6.95, t (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">5, 8a</td><td colspan="2" align="center" valign="middle" rowspan="1">122.8</td><td colspan="2" align="center" valign="middle" rowspan="1">7.14, t (7.8)</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">5, 8a</td><td colspan="2" align="center" valign="middle" rowspan="1">128.3</td><td align="center" valign="middle" rowspan="1" colspan="1">7.43, t (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">5, 8a</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">8</td><td colspan="2" align="center" valign="middle" rowspan="1">110.9</td><td colspan="2" align="center" valign="middle" rowspan="1">7.24, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td colspan="3" align="center" valign="middle" rowspan="1">4b, 6</td><td colspan="2" align="center" valign="middle" rowspan="1">112.3</td><td colspan="2" align="center" valign="middle" rowspan="1">7.36, d (7.8)</td><td colspan="2" align="center" valign="middle" rowspan="1">9</td><td colspan="2" align="center" valign="middle" rowspan="1">4b</td><td colspan="2" align="center" valign="middle" rowspan="1">113.8</td><td align="center" valign="middle" rowspan="1" colspan="1">7.54, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">4b, 6</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">8a</td><td colspan="2" align="center" valign="middle" rowspan="1">135.9</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">137.0</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">141.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">9</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">10.62, s</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 8</td><td colspan="3" align="center" valign="middle" rowspan="1">4a, 4b, 8a, 9a</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">11.46, s</td><td colspan="2" align="center" valign="middle" rowspan="1">8</td><td colspan="2" align="center" valign="middle" rowspan="1">4a, 4b, 8a, 9a</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.36, s</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 8</td><td align="center" valign="middle" rowspan="1" colspan="1">4a, 4b, 8a, 9a</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">9a</td><td colspan="2" align="center" valign="middle" rowspan="1">131.8</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">125.6</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">124.1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">10</td><td colspan="2" align="center" valign="middle" rowspan="1">169.7</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">168.7</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">163.9</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">11</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">7.90, d (9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 20&#x02032;, 22</td><td colspan="3" align="center" valign="middle" rowspan="1">10</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">8.22, d (9.0)</td><td colspan="2" align="center" valign="middle" rowspan="1">3, 20&#x02032;, 22</td><td colspan="2" align="center" valign="middle" rowspan="1">10</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.64, d (9.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 20&#x02032;, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">12</td><td colspan="2" align="center" valign="middle" rowspan="1">53.4</td><td colspan="2" align="center" valign="middle" rowspan="1">4.75, d (9.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">22, 23</td><td colspan="3" align="center" valign="middle" rowspan="1">10, 12a, 13, 22</td><td colspan="2" align="center" valign="middle" rowspan="1">53.7</td><td colspan="2" align="center" valign="middle" rowspan="1">4.69, d (9.6)</td><td colspan="2" align="center" valign="middle" rowspan="1">22, 23</td><td colspan="2" align="center" valign="middle" rowspan="1">12a, 22</td><td colspan="2" align="center" valign="middle" rowspan="1">55.0</td><td align="center" valign="middle" rowspan="1" colspan="1">4.64, d (9.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">22, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">10, 12a, 13, 22</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">12a</td><td colspan="2" align="center" valign="middle" rowspan="1">34.3</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">34.8</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">34.9</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">13</td><td colspan="2" align="center" valign="middle" rowspan="1">171.0</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">170.3</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">169.8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">15</td><td colspan="2" align="center" valign="middle" rowspan="1">55.8</td><td colspan="2" align="center" valign="middle" rowspan="1">4.89, t (10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">24, 24&#x02032;, 25</td><td colspan="3" align="center" valign="middle" rowspan="1">13, 15a, 16, 17</td><td colspan="2" align="center" valign="middle" rowspan="1">55.8</td><td colspan="2" align="center" valign="middle" rowspan="1">4.85, t (10.2)</td><td colspan="2" align="center" valign="middle" rowspan="1">24, 24&#x02032;, 25</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">56.2</td><td align="center" valign="middle" rowspan="1" colspan="1">4.85, t (10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">24, 24&#x02032;, 25</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">15a</td><td colspan="2" align="center" valign="middle" rowspan="1">28.8</td><td colspan="2" align="center" valign="middle" rowspan="1">1.91, m</td><td align="center" valign="middle" rowspan="1" colspan="1">16, 23</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">28.4</td><td colspan="2" align="center" valign="middle" rowspan="1">1.88, m</td><td colspan="2" align="center" valign="middle" rowspan="1">16, 23</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">28.6</td><td align="center" valign="middle" rowspan="1" colspan="1">1.87, m</td><td align="center" valign="middle" rowspan="1" colspan="1">16, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td colspan="2" align="center" valign="middle" rowspan="1">16</td><td colspan="2" align="center" valign="middle" rowspan="1">138.2</td><td colspan="2" align="center" valign="middle" rowspan="1">6.59, d (9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">15a, 23, 24</td><td colspan="3" align="center" valign="middle" rowspan="1">15a, 18, 25</td><td colspan="2" align="center" valign="middle" rowspan="1">138.0</td><td colspan="2" align="center" valign="middle" rowspan="1">6.59, dd (1.2, 10.2)</td><td colspan="2" align="center" valign="middle" rowspan="1">15a, 23, 24</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">138.1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.59, dd (1.2, 9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">15a, 23, 24</td><td align="center" valign="middle" rowspan="1" colspan="1">18, 25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td colspan="2" align="center" valign="middle" rowspan="1">131.7</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">131.5</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">131.7</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td colspan="2" align="center" valign="middle" rowspan="1">168.6</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">168.4</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">168.5</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td colspan="2" align="center" valign="middle" rowspan="1">43.0</td><td colspan="2" align="center" valign="middle" rowspan="1">2.43, s</td><td colspan="3" align="center" valign="middle" rowspan="1">1, 3, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 3, 9a</td><td colspan="2" align="center" valign="middle" rowspan="1">32.6</td><td colspan="2" align="center" valign="middle" rowspan="1">2.86, s</td><td colspan="2" align="center" valign="middle" rowspan="1">3, 22</td><td colspan="2" align="center" valign="middle" rowspan="1">1, 3</td><td colspan="2" align="center" valign="middle" rowspan="1">45.6</td><td colspan="2" align="center" valign="middle" rowspan="1">3.58, s</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 3, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">1, 3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td colspan="2" align="center" valign="middle" rowspan="1">30.0</td><td colspan="2" align="center" valign="middle" rowspan="1">1.37, s</td><td colspan="3" align="center" valign="middle" rowspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4, 4a, 20&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">29.8</td><td colspan="2" align="center" valign="middle" rowspan="1">1.39, s</td><td colspan="2" align="center" valign="middle" rowspan="1">3</td><td colspan="2" align="center" valign="middle" rowspan="1">3, 4, 4a, 20&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">29.8</td><td colspan="2" align="center" valign="middle" rowspan="1">1.40, s</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4, 4a, 20&#x02032;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">24.1</td><td colspan="2" align="center" valign="middle" rowspan="1">1.30, s</td><td colspan="3" align="center" valign="middle" rowspan="1">3, 5, 11</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4, 4a, 20</td><td colspan="2" align="center" valign="middle" rowspan="1">23.1</td><td colspan="2" align="center" valign="middle" rowspan="1">1.47, s</td><td colspan="2" align="center" valign="middle" rowspan="1">3, 5, 11</td><td colspan="2" align="center" valign="middle" rowspan="1">3, 4, 4a, 20</td><td colspan="2" align="center" valign="middle" rowspan="1">22.1</td><td colspan="2" align="center" valign="middle" rowspan="1">1.61, s</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 5, 11</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4, 4a, 20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td colspan="2" align="center" valign="middle" rowspan="1">26.4</td><td colspan="2" align="center" valign="middle" rowspan="1">0.90, s</td><td colspan="3" align="center" valign="middle" rowspan="1">11, 12, 19, 23, 25</td><td align="center" valign="middle" rowspan="1" colspan="1">12, 12a</td><td colspan="2" align="center" valign="middle" rowspan="1">26.0</td><td colspan="2" align="center" valign="middle" rowspan="1">0.91, s</td><td colspan="2" align="center" valign="middle" rowspan="1">11, 12, 19, 23, 25</td><td colspan="2" align="center" valign="middle" rowspan="1">12, 12a</td><td colspan="2" align="center" valign="middle" rowspan="1">26.2</td><td colspan="2" align="center" valign="middle" rowspan="1">0.94, s</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 12, 19, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">12, 12a</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td colspan="2" align="center" valign="middle" rowspan="1">30.8</td><td colspan="2" align="center" valign="middle" rowspan="1">2.87, s</td><td colspan="3" align="center" valign="middle" rowspan="1">12, 15a, 16, 22, 24&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">13, 15</td><td colspan="2" align="center" valign="middle" rowspan="1">30.7</td><td colspan="2" align="center" valign="middle" rowspan="1">2.81, s</td><td colspan="2" align="center" valign="middle" rowspan="1">12, 15a, 16, 22, 24&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">13, 15</td><td colspan="2" align="center" valign="middle" rowspan="1">31.0</td><td colspan="2" align="center" valign="middle" rowspan="1">2.82, s</td><td align="center" valign="middle" rowspan="1" colspan="1">12, 15a, 16, 22, 24&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">13, 15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td colspan="2" align="center" valign="middle" rowspan="1">19.3</td><td colspan="2" align="center" valign="middle" rowspan="1">0.77, d (6.6)</td><td colspan="3" align="center" valign="middle" rowspan="1">15, 16, 24&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 15a, 24&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">18.9</td><td colspan="2" align="center" valign="middle" rowspan="1">0.75, d (6.6)</td><td colspan="2" align="center" valign="middle" rowspan="1">15, 16, 24&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">15, 15a, 24&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">19.2</td><td colspan="2" align="center" valign="middle" rowspan="1">0.73, d (6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 16, 24&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 15a, 24&#x02032;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24&#x02032;</td><td colspan="2" align="center" valign="middle" rowspan="1">18.8</td><td colspan="2" align="center" valign="middle" rowspan="1">0.68, d (6.6)</td><td colspan="3" align="center" valign="middle" rowspan="1">15, 23, 24</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 15a, 24</td><td colspan="2" align="center" valign="middle" rowspan="1">18.3</td><td colspan="2" align="center" valign="middle" rowspan="1">0.58, d (6.6)</td><td colspan="2" align="center" valign="middle" rowspan="1">15, 23, 24</td><td colspan="2" align="center" valign="middle" rowspan="1">15, 15a, 24</td><td colspan="2" align="center" valign="middle" rowspan="1">18.5</td><td colspan="2" align="center" valign="middle" rowspan="1">0.51, d (6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 23, 24</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 15a, 24</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td colspan="2" align="center" valign="middle" rowspan="1">13.5</td><td colspan="2" align="center" valign="middle" rowspan="1">1.76, s</td><td colspan="3" align="center" valign="middle" rowspan="1">15, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">16, 17, 18</td><td colspan="2" align="center" valign="middle" rowspan="1">13.1</td><td colspan="2" align="center" valign="middle" rowspan="1">1.76, d (1.2)</td><td colspan="2" align="center" valign="middle" rowspan="1">15, 22</td><td colspan="2" align="center" valign="middle" rowspan="1">16, 17, 18</td><td colspan="2" align="center" valign="middle" rowspan="1">13.3</td><td colspan="2" align="center" valign="middle" rowspan="1">1.77, d (1.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">16, 17, 18</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18-OH</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
<sup>d</sup>
</td><td colspan="3" align="center" valign="middle" rowspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">12.40, brs</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">
</td><td colspan="2" align="center" valign="middle" rowspan="1">12.43, brs</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Compound in a FA form; <sup>b</sup> Compound in a TFA form; <sup>d</sup> Not determined; <sup>e</sup><sup>1</sup>H NMR at 600 MHz referenced to residual DMSO solvent (&#x003b4;<sub>H</sub> 2.50 ppm) and <sup>13</sup>C NMR at 150 MHz referenced to residual DMSO solvent (&#x003b4;<sub>C</sub> 39.52 ppm); <sup>f</sup><sup>13</sup>C chemical shifts obtained from correlations observed in gHSQCAD and gHMBCAD spectra.</p></fn></table-wrap-foot></table-wrap><p>Compound <bold>2</bold> was obtained as a white amorphous solid. The (+)-HRESIMS spectrum showed a signal [M + Na]<sup>+</sup> ([C<sub>30</sub>H<sub>42</sub>N<sub>4</sub>O<sub>5</sub>Na]<sup>+</sup>) at <italic>m/z</italic> 561.3045 suggesting the molecular formula C<sub>30</sub>H<sub>42</sub>N<sub>4</sub>O<sub>5</sub>. Compared with <bold>1</bold>, <bold>2</bold> lost two protons but gained one oxygen atom together with one additional degree of unsaturation. NMR data of <bold>2</bold> (<xref ref-type="table" rid="marinedrugs-12-03399-t001">Table 1</xref>) were very similar to those of <bold>1</bold> except the absence of two methylene protons H-1 in the tetrahydro-&#x003b2;-carboline residue. Detailed NMR showed that the methylene at C-1 in <bold>1</bold> was replaced by a carbonyl at &#x003b4;<sub>C</sub> 160.9 ppm, which was supported by HMBC correlations from H-3 (&#x003b4;<sub>H</sub> 4.26 ppm) and H-19 (&#x003b4;<sub>H</sub> 2.86 ppm) to C-1 (<xref ref-type="fig" rid="marinedrugs-12-03399-f003">Figure 3</xref>). The downfield chemical shift of C-4a (&#x003b4;<sub>C</sub> 121.9 ppm) confirmed its &#x003b2; position in an &#x003b1;,&#x003b2;-unsaturated carbonyl of a 2,4,4-trimethyl-2,3,4,9-tetrahydro-1<italic>H</italic>-&#x003b2;-carbolinone (<xref ref-type="fig" rid="marinedrugs-12-03399-f003">Figure 3</xref>). On the basis of these data, a planar structure of milnamide F was assigned to <bold>2</bold> (<xref ref-type="fig" rid="marinedrugs-12-03399-f003">Figure 3</xref>).</p><fig id="marinedrugs-12-03399-f003" position="float"><label>Figure 3</label><caption><p>Planar structure of <bold>2</bold> and its key HMBC correlations.</p></caption><graphic xlink:href="marinedrugs-12-03399-g003"/></fig><p>Compound <bold>3</bold> was obtained as a yellow amorphous solid. The (+)-HRESIMS spectrum displayed a molecular ion at <italic>m/z</italic> 523.3277 corresponding to the molecular formula of C<sub>30</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub><sup>+</sup> with one less proton than that of <bold>1</bold>. NMR data between <bold>3</bold> and <bold>1</bold> were comparable and the loss of one proton was found in the tetrahydro-&#x003b2;-carboline moiety. The two methylene proton signals in <bold>1</bold> were replaced by a one-proton singlet at &#x003b4;<sub>H</sub> 9.14 ppm (H-1) corresponding to a downfield sp<sup>2</sup> methine carbon at &#x003b4;<sub>C</sub> 156.8 ppm (C-1). The replacing proton H-1 (&#x003b4;<sub>H</sub> 9.14 ppm) showed HMBC correlations to C-3 (&#x003b4;<sub>C</sub> 72.2 ppm), C4a (&#x003b4;<sub>C</sub> 128.8 ppm), C-9a (&#x003b4;<sub>C</sub> 124.1 ppm) and C-19 (&#x003b4;<sub>C</sub> 45.6 ppm) and also ROESY correlations to H-9 (&#x003b4;<sub>H</sub> 12.36 ppm) and H-19 (&#x003b4;<sub>H</sub> 3.58 ppm). The location of the imine carbon C-1 (&#x003b4;<sub>C</sub> 156.8 ppm) caused a positive charge at N-2 resulting in the downfield shifts of its neighbor carbons and protons at positions 1, 3, and 19 compared with those in <bold>1</bold> and <bold>2</bold> (<xref ref-type="fig" rid="marinedrugs-12-03399-f004">Figure 4</xref>). Thus, a planar structure of <bold>3</bold> with a 2,4,4-trimethyl-4,9-dihydro-3<italic>H</italic>-&#x003b2;-carboline, named milnamide G, was established as in <xref ref-type="fig" rid="marinedrugs-12-03399-f004">Figure 4</xref>.</p><fig id="marinedrugs-12-03399-f004" position="float"><label>Figure 4</label><caption><p>Planar structure of <bold>3</bold> and its key HMBC and ROESY correlations.</p></caption><graphic xlink:href="marinedrugs-12-03399-g004"/></fig><p>We noticed that the dried milnamides A (<bold>5</bold>) and E (<bold>1</bold>) changed from white powders to yellow powders when the compounds were stored at room temperature for a few months. The LC/MS analysis showed about 5%&#x02013;10% of milnamides D (<bold>7</bold>) or G (<bold>3</bold>) had been formed in milnamides A (<bold>5</bold>) or E (<bold>1</bold>), respectively. Milnamide A (<bold>5</bold>) has previously been reported to be auto-oxidized slowly to milamide D (<bold>7</bold>) while standing in chloroform [<xref rid="B24-marinedrugs-12-03399" ref-type="bibr">24</xref>]. As in the previous study, we are unable to determine if milnamides A (<bold>5</bold>) and E (<bold>1</bold>) are naturally occurring or produced by auto-oxidation.</p><p>Chemical degradation and subsequent Marfey&#x02019;s amino acid analysis [<xref rid="B25-marinedrugs-12-03399" ref-type="bibr">25</xref>,<xref rid="B26-marinedrugs-12-03399" ref-type="bibr">26</xref>,<xref rid="B27-marinedrugs-12-03399" ref-type="bibr">27</xref>] revealed that all new compounds <bold>1</bold>&#x02013;<bold>3</bold> shared the same L configuration of the <italic>tert</italic>-leucine residue with other known milnamides and hemiasterlines (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S23</xref>). Structurally, milnamides E&#x02013;G (<bold>1</bold>&#x02013;<bold>3</bold>) differ from milnamides A, C, and D (<bold>5</bold>&#x02013;<bold>7</bold>) only by the lack of the methyl substituent at N-9. Absolute configurations of milnamides A, C, and D were previously determined by synthesis or X-ray diffraction analysis [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B24-marinedrugs-12-03399" ref-type="bibr">24</xref>]. Therefore, it has been well established that absolute configurations of the new milnamides E&#x02013;G (<bold>1</bold>&#x02013;<bold>3</bold>) can be assigned by comparing the signs of Cotton effects (CEs) and specific optical rotations [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>]. Here the new compound <bold>1</bold> showed similar CEs with milnamide A (<bold>5</bold>) and the new compound <bold>3</bold> showed similar CEs with milnamide D (<bold>7</bold>) (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S24</xref>). Their specific rotation values were also in the same sign (<bold>1</bold>, [&#x003b1;]<sup>25</sup><sub>D</sub> +11 (<italic>c</italic> 0.02, MeOH) and <bold>3</bold>, [&#x003b1;]<sup>25</sup><sub>D</sub> +134 (<italic>c</italic> 0.04, MeOH)). These data allowed the absolute configurations (3<italic>S</italic>, 12<italic>S</italic>, 15<italic>S</italic>) to be assigned to compounds <bold>1</bold> and <bold>3</bold>. So far, the CD data of milnamide C (<bold>6</bold>) has not been reported. CD spectra of <bold>6</bold> and <bold>2</bold> (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S24</xref>) showed similar CEs indicating that they had similar absolute configuration. The isolated compounds <bold>6</bold> and <bold>2</bold> showed the same positive sign of optical rotation (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S24</xref>) and the same <italic>S-</italic>configuration at C-12 in the <italic>tert</italic>-leucine residue with others milnamide derivatives. Based on biogenetic considerations, the absolute configurations of <bold>6</bold> and <bold>2</bold> were proposed as (3<italic>S</italic>, 12<italic>S</italic>, 15<italic>S</italic>).</p><p>This is the first report for the milnamides in which there is an absence of a methyl group on the indolic part. These new milnamides E-G (<bold>1</bold>&#x02013;<bold>3</bold>) were only identified from the new genus <italic>Pipestela candelabra</italic> while other milnamides A (<bold>5</bold>), C (<bold>6</bold>), and D (<bold>7</bold>) with a methyl group on the indolic part have been reported from other genera <italic>Auletta</italic> sp. [<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>,<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>], <italic>Cymbastela</italic> sp. [<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], and also from the <italic>P</italic>. <italic>candelabra</italic> in this study.</p><p>Compound <bold>4</bold> was obtained as a white amorphous solid. The (+)-HRESIMS showed a signal [M + H]<sup>+</sup> ([C<sub>46</sub>H<sub>73</sub>N<sub>6</sub>O<sub>9</sub>]<sup>+</sup>) at <italic>m/z</italic> 853.5470 indicating the molecular formula C<sub>46</sub>H<sub>72</sub>N<sub>6</sub>O<sub>9</sub>. NMR analysis revealed that this compound contained six residues including one trimethylated tryptophan (<bold>tt</bold>), two <italic>tert</italic>-leucines (<bold><italic>tert</italic>-Leu</bold>), two <italic>N</italic>-methylvinylogous valines (<bold>mvv</bold>) and one 2-hydroxyacetic acid (<bold>haa</bold>). HMBC correlations and ROESY correlations allowed establishing a tripeptide substructure <bold>A</bold> (<bold>tt-<italic>tert</italic>-Leu-mvv</bold>) (<xref ref-type="fig" rid="marinedrugs-12-03399-f005">Figure 5</xref>), which was identical to the tripeptide structure of hemiasterlin (<bold>8</bold>) and hemiasterlin A (<bold>9</bold>). The remaining atoms in <bold>4</bold> were in a side chain <bold>B</bold> whose sequence (<bold>haa-<italic>tert</italic>-Leu-mvv</bold>) was confirmed by HMBC correlations from H-30 (&#x003b4;<sub>H</sub> 4.73 ppm) to C-28 (&#x003b4;<sub>C</sub> 167.6 ppm), H-38 (&#x003b4;<sub>H</sub> 2.94 ppm) to C-31 (&#x003b4;<sub>C</sub> 170.3 ppm) (<xref ref-type="fig" rid="marinedrugs-12-03399-f005">Figure 5</xref>). The observation of HMBC correlations from H-27 (&#x003b4;<sub>H</sub> 6.34 ppm) to C-2 (&#x003b4;<sub>C</sub> 125.2 ppm) and C-9 (&#x003b4;<sub>C</sub> 136.5 ppm) supported the linkage between <bold>A</bold> and <bold>B</bold> at an indole nitrogen N-1 and C-27 (<xref ref-type="fig" rid="marinedrugs-12-03399-f005">Figure 5</xref>). This connection was supported by ROESY correlations from H-27 to H-2 (&#x003b4;<sub>H</sub> 7.20 ppm) and H-8 (&#x003b4;<sub>H</sub> 7.54 ppm). A planar structure of a new hemiasterlin, hemiasterlin D (<bold>4</bold>), was determined as in <xref ref-type="fig" rid="marinedrugs-12-03399-f005">Figure 5</xref>.</p><fig id="marinedrugs-12-03399-f005" position="float"><label>Figure 5</label><caption><p>Partial structures <bold>A</bold> and <bold>B</bold> (in bold), and key HMBC and ROESY correlations of <bold>4</bold>.</p></caption><graphic xlink:href="marinedrugs-12-03399-g005"/></fig><p>The presence of two <sc>l</sc>-<italic>tert</italic>-Leu residues in <bold>4</bold> was established since only a single peak corresponding to <sc>l</sc>-<italic>tert</italic>-Leu was observed in the ion mass extraction chromatogram of its Marfey&#x02019;s derivatives (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S23</xref>). Compound <bold>4</bold> showed the same sign of optical rotation with our isolated hemiasterlin (<bold>8</bold>) ([&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;73 (<italic>c</italic> 0.06, MeOH), lit. [&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;95 (<italic>c</italic> 0.06, MeOH) [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>]), hemiasterlin A (<bold>9</bold>) ([&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;60 (<italic>c</italic> 0.25, MeOH), lit. [&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;45 (<italic>c</italic> 0.25, MeOH) [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>]) and hemiasterlin C ([&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;18.8 (<italic>c</italic> 0.11, MeOH) [<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>]) (literature did not report the optical value of hemiasterlin B [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>]). On the basis of biogenetic considerations, the two <italic>N</italic>-methylvinylogous valines and the trimethylated tryptophan residue of <bold>4</bold> were proposed to have an <italic>S</italic>-configuration as those in the other hemiasterlin analogues. Hemiasterlin D is the first hemiasterlin with a peptide side chain containing 2-hydroxyacetic acid, <italic>tert</italic>-leucine and <italic>N</italic>-methylvinylogous valine residues at N-1.</p><p>The remaining eight known compounds including milnamide A (<bold>5</bold>) [<xref rid="B7-marinedrugs-12-03399" ref-type="bibr">7</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], milnamide C (<bold>6</bold>) [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>], milnamide D (<bold>7</bold>) [<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], hemiasterlin (or milnamide B) (<bold>8</bold>) [<xref rid="B4-marinedrugs-12-03399" ref-type="bibr">4</xref>,<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>,<xref rid="B8-marinedrugs-12-03399" ref-type="bibr">8</xref>,<xref rid="B9-marinedrugs-12-03399" ref-type="bibr">9</xref>], hemiasterlin A (<bold>9</bold>) [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>], geodiamolide D (<bold>10</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>], geodiamolide E (<bold>11</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>], and geodiamolide F (<bold>12</bold>) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-12-03399" ref-type="bibr">20</xref>] were all identified by comparisons of the NMR, MS and optical rotation values with those in the literature.</p><p>Antiproliferative effect of isolated compounds was evaluated against the human prostate cancer cell line (PC3) and the human neonatal foreskin fibroblast non-cancer cell line (NFF). All compounds showed potent inhibition against prostate cancer cells with IC<sub>50</sub> values from the picomolar to sub-micromolar range (<xref ref-type="table" rid="marinedrugs-12-03399-t002">Table 2</xref>). Selective indexes between PC3 cells and NFF cells were from 2.6 to 8.3 indicating these compounds had some selective activity towards prostate cancer cells. Cytotoxic results also indicated that breaking the &#x003b2;-carboline system in milnamides to form the tryptophan system in hemiasterlins increased cytotoxicity.</p><p>In the milnamide family, milnamide A (<bold>5</bold>) exhibited the strongest activity (IC<sub>50</sub> = 11.0 nM) and was 3-fold more potent than milnamide C (<bold>6</bold>) and 35-fold more potent than milnamide C (<bold>7</bold>). A similar trend was observed in the activity of milnamide E to G (<bold>1</bold>&#x02013;<bold>3</bold>). The results indicated that replacing the methylene at C-1 with a carbonyl or an imine led to a decrease in cytotoxicity. Losing the <italic>N</italic>-methyl at <italic>N</italic>-9 in the &#x003b2;-carboline ring converting <bold>5</bold> to <bold>1</bold>, <bold>6</bold> to <bold>2</bold>, and <bold>7</bold> to <bold>3</bold> also reduced the activity. These data suggested that the <italic>N</italic>-methyl at N-9 might contribute to the milnamide cytotoxicity.</p><table-wrap id="marinedrugs-12-03399-t002" position="float"><object-id pub-id-type="pii">marinedrugs-12-03399-t002_Table 2</object-id><label>Table 2</label><caption><p>Cytotoxic evaluation for compounds <bold>1</bold>&#x02013;<bold>12</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" colspan="1">Compound</th><th style="border-bottom:solid thin" colspan="2" align="center" valign="middle" rowspan="1">IC50 (nM) or% Inhibition <sup>a</sup></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">PC3</th><th align="center" valign="middle" rowspan="1" colspan="1">NFF</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">34.2</td><td align="center" valign="middle" rowspan="1" colspan="1">123</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2180</td><td align="center" valign="middle" rowspan="1" colspan="1">5650</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2870</td><td align="center" valign="middle" rowspan="1" colspan="1">39% at 10 &#x003bc;M</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.20</td><td align="center" valign="middle" rowspan="1" colspan="1">8.16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11.0</td><td align="center" valign="middle" rowspan="1" colspan="1">70.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>6</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">31.7</td><td align="center" valign="middle" rowspan="1" colspan="1">188</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>7</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">381</td><td align="center" valign="middle" rowspan="1" colspan="1">1190</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>8</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0484</td><td align="center" valign="middle" rowspan="1" colspan="1">0.404</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>9</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.269</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>10</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">33.1</td><td align="center" valign="middle" rowspan="1" colspan="1">99.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>11</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">118</td><td align="center" valign="middle" rowspan="1" colspan="1">425</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>12</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">155</td><td align="center" valign="middle" rowspan="1" colspan="1">708</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Taxol</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.26</td><td align="center" valign="middle" rowspan="1" colspan="1">3.94</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Doxorubicin</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">359</td><td align="center" valign="middle" rowspan="1" colspan="1">530</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Each IC<sub>50</sub> (nM) or % inhibition at 10 &#x003bc;M was determined as the mean of two independent experiments with triplicate determinations for each concentration.</p></fn></table-wrap-foot></table-wrap><p>Compared with milnamides (<bold>1</bold>&#x02013;<bold>3</bold> and <bold>5</bold>&#x02013;<bold>7</bold>), hemiasterlins (<bold>4</bold>, <bold>8</bold>, and <bold>9</bold>) demonstrated much more potent cytotoxicity and showed higher selectivity towards noncancer cells. Their activity against the PC3 cells was in the picomolar to sub-nanomolar range. In the examination of hemiasterlins, Andersen <italic>et al</italic>. [<xref rid="B10-marinedrugs-12-03399" ref-type="bibr">10</xref>] found that the <italic>N</italic>-methyl indole had better activity than the NH indole. Here a methyl at the indole nitrogen N-1 in hemiasterlin (<bold>8</bold>) was found six-fold more cytotoxic than an NH indole in hemiastermin A (<bold>9</bold>). This cytotoxicity result was comparable with those reported for other cancer cell lines [<xref rid="B5-marinedrugs-12-03399" ref-type="bibr">5</xref>,<xref rid="B6-marinedrugs-12-03399" ref-type="bibr">6</xref>]. In our study, the new compound, hemiasterlin D (<bold>4</bold>) showed inhibition with IC<sub>50</sub> values of 2.20 and 8.16 nM for PC3 and NFF cells, respectively. Although the new hemiasterlin D (<bold>4</bold>) here was less potent than the known analogues, the results showed that cytotoxicity was maintained when replacing the methyl of the <italic>N</italic>-methylindole in the tetramethyltryptophan residue with a long side chain. This result may offer a new position at N-1 for hemiasterlin to be developed for more selective activity and better pharmaceutical properties.</p><p>The three depsipeptides, geodiamolides D&#x02013;F (<bold>10</bold>&#x02013;<bold>12</bold>), which were found co-occurring with the milnamides and hemiasterlins, also displayed strong cytotoxic activity against the PC3 cells and showed 3- to 5-fold selectivity with the NFF cells. Geodiamolide D (<bold>10</bold>) showed the strongest activity with an IC<sub>50</sub> value of 33.1 nM, which was 4-fold more potent than geodiamolide E (<bold>11</bold>) and 5-fold more active than geodiamolide F (<bold>12</bold>). This data indicated that there was a difference in cytotoxicity due to the halogen atoms attached to the geodiamolide skeleton. The cytotoxic trend of geodiamolides D&#x02013;F (<bold>10</bold>&#x02013;<bold>12</bold>) against PC3 cells decreased from iodine to bromine and chlorine. This trend in the human PC3 cell line was totally different from the previous cytotoxic trend reported for these compounds in the murine leukemia L1210 cell line (IC<sub>50</sub> values of 62.2, 24.2, and 11.2 nM for geodiamolides D, E and F, respectively) [<xref rid="B19-marinedrugs-12-03399" ref-type="bibr">19</xref>]. How these halogen atoms influence cytotoxicity is something that warrants further investigation.</p></sec><sec><title>3. Experimental Section</title><sec sec-type="methods"><title>3.1. General Experimental Procedures</title><p>Optical rotations were measured on JASCO P-1020 polarimeter (10 cm cell). Circular dichroism spectra were measured on JASCO J-715 Spectropolarimeter Circular Dichroism/Optical Rotatory Dispersion. UV spectra were recorded on a CAMSPEC M501 UV/VIS spectrophotometer. NMR spectra were recorded at 30 &#x000b0;C on a Varian Inova 600 MHz spectrometer. The <sup>1</sup>H and <sup>13</sup>C chemical shift were referenced to the DMSO-<italic>d<sub>6</sub></italic> solvent peak at &#x003b4;<sub>H</sub> 2.50 and &#x003b4;<sub>C</sub> 39.52 ppm. Standard parameters were used for the 2D NMR spectra obtained, which included gCOSY, gHSQCAD (<sup>1</sup><italic>J</italic><sub>CH</sub> = 140 Hz), gHMBCAD (<italic><sup>n</sup>J</italic><sub>CH</sub> = 8 Hz) and ROESY. Mass spectra were acquired using a Mariner TOF mass spectrometer (Applied Biosystems Pty Ltd.). High-resolution mass measurement was acquired on a Bruker Solarix 12 Tesla Fourier transform mass spectrometer, fitted with an Apollo API source. For the HPLC isolation, a Water 600 pump equipped with a Water 966 PDA detector and Gilson 715 liquid handler were used. A Betasil C<sub>18</sub> column (5 &#x003bc;m, 21.2 &#x000d7; 150 mm) and Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) were used for semipreparative HPLC. A Phenomenex Luna C<sub>18</sub> column (3 &#x003bc;m, 4.6 &#x000d7; 50 mm) was used for LC/MS controlled by MassLynx 4.1 software. All solvents used for extraction and chromatography were HPLC grade from RCI Labscan or Burdick &#x00026; Jackson, and the H<sub>2</sub>O used was ultrapure water (Arium<sup>&#x000ae;</sup> proVF) from Sartorius Stedim Biotech.</p></sec><sec><title>3.2. Animal Material</title><p>A first sample of <italic>P</italic>. <italic>candelabra</italic> was collected at the depth of 36 m, Wilson Reef, Coral Sea, Queensland, Australia. It was identified as <italic>Pipestela candelabra</italic> (phylum Porifera, class Demospongiae, order Halichondrida, family Axinellidae). A voucher specimen QMG320579 has been deposited at the Queensland Museum, South Brisbane, Queensland, Australia.</p><p>A second sample characterised as the same taxonomy with the first specimen <italic>Pipestela candelabra</italic> was collected at the depth of 20 m, Houghton Reef, Howick Group, Queensland, Australia. A voucher specimen QMG320790 has been deposited at the Queensland Museum, South Brisbane, Queensland, Australia.</p></sec><sec><title>3.3. Extraction and Isolation</title><p>A first freeze-dried sample of <italic>P</italic>. <italic>candelabra</italic> (19 g) collected at Wilson Reef, Coral Sea was extracted exhaustively with hexane (250 mL), dichloromethane (DCM) (3 &#x000d7; 250 mL) and MeOH (3 &#x000d7; 250 mL), respectively. The DCM and MeOH extracts were combined and then evaporated solvents to yield a yellow residue (2.6 g). This crude extract was pre-adsorbed onto C<sub>18</sub> (1.0 g) and packed dry into a small cartridge, which was connected to a C<sub>18</sub> preparative HPLC column (5 &#x003bc;m, 21.2 &#x000d7; 150 mm). A linear gradient from 100% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) was performed over 60 min at a flow rate of 9.0 mL/min and 60 fractions (1.0 min each) were collected. Fractions 39&#x02013;40 were combined and loaded on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a linear gradient from 60% MeOH (0.1% TFA)&#x02013;40% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) at a flow rate of 4 mL/min in 60 min yielding <bold>6</bold> (1.2 mg, 0.006% dry wt). Fractions 30&#x02013;38 were combined and chromatographed on the Betasil C<sub>18</sub> column (5 &#x003bc;m, 21.2 x 150 mm) from 50% MeOH (0.1% TFA)&#x02013;50% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) in 60 min. Three pure compounds were isolated including <bold>7</bold> (2.5 mg, 0.013% dry wt), <bold>8</bold> (4 mg, 0.021% dry wt), and <bold>9</bold> (5 mg, 0.026% dry wt). Fraction 47 was further purified on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a linear gradient from 40% MeOH (0.1% TFA)&#x02013;60% H<sub>2</sub>O (0.1% TFA) to 45% MeOH (0.1% TFA)&#x02013;55% H<sub>2</sub>O (0.1% TFA) at a flow rate of 4 mL/min in 45 min yielding <bold>3</bold> (1.5 mg, 0.008% dry wt) and <bold>7</bold> (0.5 mg, 0.003% dry wt). Fraction 50 was loaded on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a linear gradient from 45% MeOH (0.1% TFA)&#x02013;55% H<sub>2</sub>O (0.1% TFA) to 55% MeOH (0.1% TFA)&#x02013;45% H<sub>2</sub>O (0.1% TFA) at a flow rate of 4 mL/min in 60 min resulting in the purification of compounds <bold>1</bold> (0.8 mg, 0.004% dry wt) and <bold>5</bold> (1 mg, 0.005% dry wt). Fraction 53 was also subjected on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a linear gradient from 50% MeOH (0.1% TFA)&#x02013;50% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) at a flow rate of 4 mL/min in 60 min to obtain <bold>10</bold> (3.1 mg, 0.016% dry wt) and <bold>11</bold> (2.1 mg, 0.011% dry wt). Fractions 55&#x02013;56 were also loaded on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a linear gradient from 50% MeOH (0.1% TFA)&#x02013;50% H<sub>2</sub>O (0.1% TFA) to 65% MeOH (0.1% TFA)&#x02013;35% H<sub>2</sub>O (0.1% TFA) at a flow rate of 4 mL/min in 60 min yielding <bold>2</bold> (0.9 mg, 0.005% dry wt) and <bold>12</bold> (0.5 mg, 0.003% dry wt).</p><p>A second freeze-dried sample of <italic>P</italic>. <italic>candelabra</italic> (30 g) collected at Houghton Reef, Howick Group, was also extracted exhaustively with hexane (750 mL), DCM (4 &#x000d7; 250 mL) and MeOH (4 &#x000d7; 250 mL), respectively. The DCM and MeOH extracts were combined and then evaporated solvents to yield a yellow residue (7.5 g). This crude extract was pre-adsorbed onto C<sub>18</sub> (10 g) and packed dry into a cartridge (25 &#x000d7; 50 mm), which was connected to a C<sub>18</sub> preparative HPLC column (5 &#x003bc;m, 50 &#x000d7; 150 mm). A linear gradient from 100% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) was performed over 90 min at a flow rate of 20 mL/min and 180 fractions (0.5 min each) were collected. Fractions 111 to 114 were then combined and further purified by a Betasil C<sub>18</sub> column (5 &#x003bc;m, 21.2 &#x000d7; 150 mm) using a linear gradient from 45% MeOH (0.1% TFA)&#x02013;55% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) in 60 min. Compounds <bold>7</bold> (1.0 mg, 0.0033% dry wt), <bold>9</bold> (12.0 mg, 0.0400% dry wt) and <bold>4</bold> (0.8 mg, 0.0026% dry wt) were obtained. A 15 mg mixture of compounds <bold>5</bold> and <bold>1</bold> in fractions 115 to 124 was subjected on the Hypersil BDS C<sub>18</sub> column (5 &#x003bc;m, 10 &#x000d7; 250 mm) with a 60 min linear gradient from 50% MeOH (0.1% FA)&#x02013;50% H<sub>2</sub>O (0.1% FA) to 100% MeOH (0.1% FA) yielding <bold>1</bold> (2.5 mg, 0.0083% dry wt) and <bold>5</bold> (2.0 mg, 0.0067% dry wt). The combined fractions 125 to 132 were also chromatographed on the Betasil C<sub>18</sub> column (5 &#x003bc;m, 21.2 &#x000d7; 150 mm) from 50% MeOH (0.1% TFA)&#x02013;50% H<sub>2</sub>O (0.1% TFA) to 100% MeOH (0.1% TFA) in 60 min. Six compounds were purified, including compounds <bold>8</bold> (18.0 mg, 0.06% dry wt), <bold>12</bold> (1.0 mg, 0.0033% dry wt), <bold>11</bold> (7.0 mg, 0.0233% dry wt), <bold>10</bold> (15.0 mg, 0.05% dry wt) and <bold>6</bold> (0.5 mg, 0.0017% dry wt), respectively.</p><p><bold>Milnamide E (1):</bold> white amorphous solid; [&#x003b1;]<sup>25</sup><sub>D</sub> +11 (<italic>c</italic> 0.02, MeOH); CD (MeOH) &#x003bb;<sub>max</sub> (&#x02206;&#x003b5;) 245 (&#x02212;3.9), 266 (+0.38) nm; UV (MeOH) &#x003bb;<sub>max</sub> (log&#x003b5;) 227 (4.3), 290 (3.4) nm; <sup>1</sup>H (600 MHz) and <sup>13</sup>C (150 MHz) NMR data are summarized in <xref ref-type="table" rid="marinedrugs-12-03399-t001">Table 1</xref>; (+) HRESIMS <italic>m/z</italic> 525.3418 ([M + H]<sup>+</sup>) (calcd (+) <italic>m/z</italic> 525.3435, &#x02206; &#x02212;3.2 ppm).</p><p><bold>Milnamide F (2):</bold> white amorphous solid; [&#x003b1;]<sup>25</sup><sub>D</sub> +29 (<italic>c</italic> 0.05, MeOH); CD (MeOH) &#x003bb;<sub>max</sub> (&#x02206;&#x003b5;) 241 (&#x02212;1.2), 260 (+3.1), 329 (+2.6) nm; UV (MeOH) &#x003bb;<sub>max</sub> (log&#x003b5;) 210 (3.6), 306 (3.1) nm; <sup>1</sup>H (600 MHz) and <sup>13</sup>C (150 MHz) NMR data are summarized in <xref ref-type="table" rid="marinedrugs-12-03399-t001">Table 1</xref>; (+) HRESIMS <italic>m/z</italic> 561.3045 ([M + Na]<sup>+</sup>) (calcd (+) <italic>m/z</italic> 561.3047, &#x02206; &#x02212;0.36 ppm).</p><p><bold>Milnamide G (3):</bold> yellow amorphous solid; [&#x003b1;]<sup>25</sup><sub>D</sub> +134 (<italic>c</italic> 0.04, MeOH); CD (MeOH) &#x003bb;<sub>max</sub> (&#x02206;&#x003b5;) 240 (&#x02212;1.96), 284 (+0.58), 371 (&#x02212;1.4), 438 (+5.0) nm; UV (MeOH) &#x003bb;<sub>max</sub> (log&#x003b5;) 207 (4.1), 378 (3.7) nm; <sup>1</sup>H (600 MHz) and <sup>13</sup>C (150 MHz) NMR data are summarized in <xref ref-type="table" rid="marinedrugs-12-03399-t001">Table 1</xref>; (+) HRESIMS <italic>m/z</italic> 523.3277 ([M + H]<sup>+</sup>) (calcd (+) <italic>m/z</italic> 523.3279, &#x02206; &#x02212;0.38 ppm).</p><p><bold>Hemiasterlin D (4):</bold> white amorphous solid; [&#x003b1;]<sup>25</sup><sub>D</sub> &#x02212;52 (<italic>c</italic> 0.02, MeOH); UV (MeOH) &#x003bb;<sub>max</sub> (log&#x003b5;) 225 (4.3), 270 (3.3) nm; <sup>1</sup>H (600 MHz) and <sup>13</sup>C (150 MHz) NMR data are summarized in <xref ref-type="table" rid="marinedrugs-12-03399-t003">Table 3</xref>; (+) HRESIMS <italic>m/z</italic> 853.5470 ([M + H]<sup>+</sup>) (calcd (+) <italic>m/z</italic> 853.5434, &#x02206; 4.2 ppm).</p><table-wrap id="marinedrugs-12-03399-t003" position="float"><object-id pub-id-type="pii">marinedrugs-12-03399-t003_Table 3</object-id><label>Table 3</label><caption><p>NMR data for TFA salt of hemiasterlin D (<bold>4</bold>) recorded in DMSO-<italic>d<sub>6</sub></italic>
<sup>a</sup> at 30 &#x000b0;C.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Position</th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;<sub>C</sub><sup>b</sup></th><th align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;<sub>H</sub> (<italic>J</italic> in Hz)</th><th align="center" valign="middle" rowspan="1" colspan="1">gCOSY</th><th align="center" valign="middle" rowspan="1" colspan="1">ROESY</th><th align="center" valign="middle" rowspan="1" colspan="1">gHMBCAD</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">125.2</td><td align="center" valign="middle" rowspan="1" colspan="1">7.20, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">22, 27</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 4, 9, 10, 27</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">118.0</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">125.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">120.2</td><td align="center" valign="middle" rowspan="1" colspan="1">8.11, d (7.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">7, 9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">119.0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.11, t (7.2, 7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">5, 7</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">4, 8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">121.2</td><td align="center" valign="middle" rowspan="1" colspan="1">7.15, t (7.2, 7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">6, 8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">5, 9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">110.8</td><td align="center" valign="middle" rowspan="1" colspan="1">7.54, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">4, 6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">136.5</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">37.6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">66.9</td><td align="center" valign="middle" rowspan="1" colspan="1">4.47, d (10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1">5, 13, 21, 22</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">165.9</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.90, d (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">55.4</td><td align="center" valign="middle" rowspan="1" colspan="1">4.87, d (7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">24, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">12, 14a, 15, 23</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14a</td><td align="center" valign="middle" rowspan="1" colspan="1">34.5</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">169.9</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">56.0</td><td align="center" valign="middle" rowspan="1" colspan="1">4.93, t (9.6, 10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">17a, 18 </td><td align="center" valign="middle" rowspan="1" colspan="1">25, 25&#x02032;, 26</td><td align="center" valign="middle" rowspan="1" colspan="1">17a, 18, 19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17a</td><td align="center" valign="middle" rowspan="1" colspan="1">28.6</td><td align="center" valign="middle" rowspan="1" colspan="1">2.03, m</td><td align="center" valign="middle" rowspan="1" colspan="1">17, 25, 25&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">18, 24</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">138.0</td><td align="center" valign="middle" rowspan="1" colspan="1">6.68, d (9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">24, 17a, 25</td><td align="center" valign="middle" rowspan="1" colspan="1">20, 26</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">131.7</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">168.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">33.3</td><td align="center" valign="middle" rowspan="1" colspan="1">2.24, t (4.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">NH</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">26.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.37, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">5, 11</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 10, 11, 22&#x02032;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">21.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.38, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3, 10, 11, 22</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">26.1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.01 (s)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">14, 24</td><td align="center" valign="middle" rowspan="1" colspan="1">14, 14a</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">31.0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.04 (s)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">14, 17a, 18, 23</td><td align="center" valign="middle" rowspan="1" colspan="1">15, 17</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">19.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.82, d (6.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">17, 17a, 25&#x02032;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">19.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81, d (6.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">17, 17a, 25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">13.3</td><td align="center" valign="middle" rowspan="1" colspan="1">1.80, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">18, 19, 20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">76.3</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2, 8, 29</td><td align="center" valign="middle" rowspan="1" colspan="1">2, 9, 28</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">167.6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.10, d (8.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">27, 37</td><td align="center" valign="middle" rowspan="1" colspan="1">28</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">53.9</td><td align="center" valign="middle" rowspan="1" colspan="1">4.73, d (9.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">37, 38</td><td align="center" valign="middle" rowspan="1" colspan="1">28, 30a, 31, 37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30a</td><td align="center" valign="middle" rowspan="1" colspan="1">34.8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">170.3</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">55.5</td><td align="center" valign="middle" rowspan="1" colspan="1">5.01, t (9.6, 10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">33a, 34</td><td align="center" valign="middle" rowspan="1" colspan="1">39, 39&#x02032;, 40</td><td align="center" valign="middle" rowspan="1" colspan="1">31, 33a, 34, 35, 38</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">33a</td><td align="center" valign="middle" rowspan="1" colspan="1">28.5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.97, m</td><td align="center" valign="middle" rowspan="1" colspan="1">33, 39, 39&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">34, 38</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">137.8</td><td align="center" valign="middle" rowspan="1" colspan="1">6.64, d (9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">33a, 38</td><td align="center" valign="middle" rowspan="1" colspan="1">36, 40</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">132.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">168.3</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">25.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.88, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">29, 30, 38, 40</td><td align="center" valign="middle" rowspan="1" colspan="1">30, 30a</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">30.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.94, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">30, 33a, 34, 37</td><td align="center" valign="middle" rowspan="1" colspan="1">31, 33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">18.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79, d (6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">33, 33a, 39&#x02032;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">39&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">18.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.74, d (6.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">33, 33<sup>a</sup>, 39</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">13.3</td><td align="center" valign="middle" rowspan="1" colspan="1">1.80, s</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">34, 35, 36</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11-NH</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">8.88, brs<break/>7.51, brs</td><td align="center" valign="middle" rowspan="1" colspan="1">11, 21<break/>21</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20-OH/36-OH</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.4, brs</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>
<sup>1</sup>H NMR at 600 MHz referenced to residual DMSO solvent (&#x003b4;<sub>H</sub> 2.50 ppm) and <sup>13</sup>C NMR at 150 MHz referenced to residual DMSO solvent (&#x003b4;<sub>C</sub> 39.52 ppm); <sup>b</sup>
<sup>13</sup>C chemical shifts obtained from correlations observed in gHSQCAD and gHMBCAD spectra.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>3.4. Peptide Hydrolysis and LC/MS Analysis of Marfey&#x02019;s Derivatives</title><p>Peptide samples (150 &#x003bc;g) were dissolved in degassed 6 N HCl (500 &#x003bc;L) and heated at 120 &#x000b0;C for 8 h. The solvent was removed under dry nitrogen and the resulting material was subjected to further derivatization for a stereochemical assignment.</p><p>The hydrolysate mixture or the amino acid standard was added a solution of <sc>l</sc>-FDAA 1% (w/w) in acetone and 100 &#x003bc;L of a 1 N NaHCO<sub>3</sub> solution. The vial was heated at 50 &#x000b0;C for 3 h and the contents were neutralized with 2 N HCl (50 &#x003bc;L) after cooling to room temperature. An aliquot of the <sc>l</sc>-FDAA derivative was dried under dry nitrogen, diluted in MeOH and loaded on a Phenomenex Luna column (C<sub>18</sub>, 3 &#x003bc;m, 4.6 mm &#x000d7; 50 mm) using a linear gradient from 5% MeOH (0.1% FA)&#x02013;95% H<sub>2</sub>O (0.1% FA) to 100% MeOH (0.1% FA) in 12 min. FDAA derivatives were detected by absorption at 340 nm and assignment was secured by ion mass extraction.</p><p>Retention times of authentic FDAA-amino acids are given in parenthesis: <sc>l</sc>-<italic>tert</italic>-Leu (8.66 min) and <sc>d</sc>-<italic>tert</italic>-Leu (9.33 min). The hydrolysate of milnamide E (<bold>1</bold>), milnamide F (<bold>2</bold>), milnamide G (<bold>3</bold>), and hemiasterlin D (<bold>4</bold>) contained <sc>l</sc>-<italic>tert</italic>-Leu eluted at 8.65, 8.72, 8.67, and 8.68 min, respectively (<xref ref-type="supplementary-material" rid="marinedrugs-12-03399-s001">Supplementary Figure S23</xref>).</p></sec><sec><title>3.5. Cytotoxicity Assay</title><p>Human prostate adenocarcinoma cells (PC3) and human neonatal foreskin fibroblast (noncancer cells, NFF) were grown in media RPMI-1640 (Life Technologies, Grand Island, NY, USA) supplemented with 10% foetal bovine serum (FBS). Cells were grown under 5% CO<sub>2</sub> in a humidified environment at 37&#x000b0;C. Fifty microlitres of media containing 500 cells were added to a 384 well microtitre plate (Perkin Elmer, Waltham, MA, USA, part number: 6007660) containing 0.2 &#x003bc;L of a compound. Final compound concentration range tested was 10 &#x003bc;M to 1 pM (final DMSO concentration of 0.4%). Each concentration in media was tested in triplicate and in two independent experiments. Cells and compounds were then incubated in 72 h at 37 &#x000b0;C, 5% CO<sub>2</sub> and 80% humidity. Cell proliferation was measured with the addition of 10 &#x003bc;L of a 60% Alamar blue (Invitrogen, Carlsbad, CA, USA) solution in media to each well of the microtitre plate to give a final concentration of 10% Alamar blue. The plates were incubated at 37 &#x000b0;C, 5% CO<sub>2</sub> and 80% humidity within 24 h. The fluorescence of each well was read at excitation 535 nm and emission 590 nm on the Perkin Elmer EnVision Multilabel Reader 2104. Eight-point concentration response curves were then analysed using non-linear regression and IC<sub>50</sub> values determined by using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA, USA). Paclitaxel and doxorubicin were used during each screening as positive control compounds.</p></sec></sec><sec><title>4. Conclusions</title><p>Contributing to the chemical investigation of the new sponge genus <italic>Pipestela candelabra</italic>, twelve secondary metabolites belonging to three structure classes including milnamide, hemiasterlin and geodiamolide were isolated. Three new members of the milnamide family, milnamides E&#x02013;G (<bold>1</bold>&#x02013;<bold>3</bold>), and one new member of the hemiasterlin family, hemiasterlin D (<bold>4</bold>), were identified. Milnamides F (<bold>2</bold>) and G (<bold>3</bold>) were identified in the sponge collected at Wilson Reef while hemiasterlin D was only discovered in the sample collected at Houghton Reef. However, all three structure classes were found in samples of the <italic>P</italic>. <italic>candelabra</italic> collected at two locations which are 124 km apart. </p><p>All new and known natural products showed potent and selective inhibition against the human prostate cancer cells (PC3). Hemiasterlin D (<bold>4</bold>) is the first example of a hemiasterlin substituted at N-1 by a peptide side chain, which is identical to the peptide side chain at N-13. The compound has less cytotoxicity (IC<sub>50</sub> of 2.20 nM) compared to hemiasterlin (<bold>8</bold>) and hemiasterlin A (<bold>9</bold>) (IC<sub>50</sub> of 0.0484 nM and 0.269 nM, respectively) but it opens the possibility for further structural variation at N-1. This is a first report of the preliminary structure-activity relationships of the milnamide family. The C-1 and N-9 in milnamides are important positions affecting their cytotoxicity in PC3 cells.</p></sec></body><back><ack><title>Acknowledgments</title><p>One of the authors (T. D. Tran) acknowledges Education Australia Ltd. for the provision of the &#x0201c;EAL Postgraduate Research Student Mobility Scholarships&#x0201d; and Griffith University for the provision of the GUIPRS and GUPRS scholarships. We thank H. T. Vu for acquiring the HRESIMS measurements. </p></ack><app-group><app><title>Supplementary Files</title><supplementary-material content-type="local-data" id="marinedrugs-12-03399-s001"><label>Supplementary File 1</label><caption><p>Supplementary Information (PDF, 3596 KB)</p></caption><media xlink:href="marinedrugs-12-03399-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Ronald J. Quinn conceived and designed the research. Ronald J. Quinn and Ngoc B. Pham supervised the chemical experiments and structure elucidation. Gregory A. Fechner supervised the biological experiments. Trong D. Tran performed the natural product isolation, structural identification and cytotoxicity assays. John N. A. Hooper collected and identified the sponge samples. Trong D. Tran, Ngoc B. Pham and Ronald J. Quinn interpreted the results and wrote the manuscript. </p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-12-03399"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>B.</given-names></name><name><surname>Hooper</surname><given-names>J.N.A.</given-names></name><name><surname>Soest</surname><given-names>R.W.M.V.</given-names></name></person-group>
<article-title><italic>Pipestela</italic>, a new genus of Axinellidae (Polifera: Demospongiae: Halichondrida) and description of three new species</article-title>
<source>Mem. Queensl. Mus.</source>
<year>2008</year>
<volume>52</volume>
<fpage>105</fpage>
<lpage>118</lpage>
</element-citation></ref><ref id="B2-marinedrugs-12-03399"><label>2.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Hooper</surname><given-names>J.</given-names></name><name><surname>Soest</surname><given-names>R.V.</given-names></name></person-group>
<source>Systema Porifera: A Guide to the Classification of Sponges</source>
<publisher-name>Kluwer Academic/Plenum</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2002</year>
</element-citation></ref><ref id="B3-marinedrugs-12-03399"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sorres</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>M.T.</given-names></name><name><surname>Petek</surname><given-names>S.</given-names></name><name><surname>Levaique</surname><given-names>H.</given-names></name><name><surname>Cresteil</surname><given-names>T.</given-names></name><name><surname>Ramos</surname><given-names>S.</given-names></name><name><surname>Thoison</surname><given-names>O.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Mourabit</surname><given-names>A.A.</given-names></name></person-group>
<article-title>Pipestelides A&#x02013;C: Cyclodepsipeptides from the Pacific marine sponge <italic>Pipestela candelabra</italic></article-title>
<source>J. Nat. Prod.</source>
<year>2012</year>
<volume>75</volume>
<fpage>759</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1021/np200714m</pub-id>
<pub-id pub-id-type="pmid">22364566</pub-id></element-citation></ref><ref id="B4-marinedrugs-12-03399"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Talpir</surname><given-names>R.</given-names></name><name><surname>Benayahu</surname><given-names>Y.</given-names></name><name><surname>Kasman</surname><given-names>Y.</given-names></name><name><surname>Pannell</surname><given-names>L.</given-names></name><name><surname>Schleyer</surname><given-names>M.</given-names></name></person-group>
<article-title>Hemiasterlin and Geodiamolide TA; Two new cytotoxic peptides from the marine sponge <italic>Hemiasterella minor</italic> (Kirkpatrick)</article-title>
<source>Tetrahedron Lett.</source>
<year>1994</year>
<volume>35</volume>
<fpage>4453</fpage>
<lpage>4456</lpage>
<pub-id pub-id-type="doi">10.1016/S0040-4039(00)73382-X</pub-id>
</element-citation></ref><ref id="B5-marinedrugs-12-03399"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J.E.</given-names></name><name><surname>Silva</surname><given-names>E.D.D.</given-names></name><name><surname>Kong</surname><given-names>F.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Allen</surname><given-names>T.M.</given-names></name></person-group>
<article-title>Cytotoxic peptides from the marine sponge <italic>Cymbastela</italic> sp</article-title>
<source>Tetrahedron</source>
<year>1995</year>
<volume>51</volume>
<fpage>10653</fpage>
<lpage>10662</lpage>
<pub-id pub-id-type="doi">10.1016/0040-4020(95)00646-P</pub-id>
</element-citation></ref><ref id="B6-marinedrugs-12-03399"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gamble</surname><given-names>W.R.</given-names></name><name><surname>Durso</surname><given-names>N.A.</given-names></name><name><surname>Fuller</surname><given-names>R.W.</given-names></name><name><surname>Westergaard</surname><given-names>C.K.</given-names></name><name><surname>Johnson</surname><given-names>T.R.</given-names></name><name><surname>Sachkett</surname><given-names>D.L.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Cardellina</surname><given-names>J.H.</given-names></name><name><surname>Boyd</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Cytotoxic and tubulin-interative hemiasterlins from <italic>Auletta</italic> sp. and <italic>Siphonochalina</italic> spp. sponges</article-title>
<source>Bioorg. Med. Chem.</source>
<year>1999</year>
<volume>7</volume>
<fpage>1611</fpage>
<lpage>1615</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0896(99)00089-9</pub-id>
<pub-id pub-id-type="pmid">10482453</pub-id></element-citation></ref><ref id="B7-marinedrugs-12-03399"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crews</surname><given-names>P.</given-names></name><name><surname>Farias</surname><given-names>J.J.</given-names></name><name><surname>Emrich</surname><given-names>R.</given-names></name><name><surname>Keifer</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Milnamide A, an unusual cytotoxic tripeptide from the marine sponge <italic>Auletta</italic> cf. <italic>constricta</italic></article-title>
<source>J. Org. Chem.</source>
<year>1994</year>
<volume>59</volume>
<fpage>2932</fpage>
<lpage>2934</lpage>
</element-citation></ref><ref id="B8-marinedrugs-12-03399"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sonnenschein</surname><given-names>R.N.</given-names></name><name><surname>Farias</surname><given-names>J.J.</given-names></name><name><surname>Tenney</surname><given-names>K.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Lobkovsky</surname><given-names>E.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group>
<article-title>A further study of the cytotoxic constituents of a milnamide-producing sponge</article-title>
<source>Org. Lett.</source>
<year>2004</year>
<volume>6</volume>
<fpage>779</fpage>
<lpage>782</lpage>
<pub-id pub-id-type="doi">10.1021/ol036446c</pub-id>
<pub-id pub-id-type="pmid">14986973</pub-id></element-citation></ref><ref id="B9-marinedrugs-12-03399"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chevallier</surname><given-names>C.</given-names></name><name><surname>Richardson</surname><given-names>A.D.</given-names></name><name><surname>Edler</surname><given-names>M.C.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Harper</surname><given-names>M.K.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name></person-group>
<article-title>A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge <italic>Cymbastela</italic> sp</article-title>
<source>Org. Lett.</source>
<year>2003</year>
<volume>5</volume>
<fpage>3737</fpage>
<lpage>3739</lpage>
<pub-id pub-id-type="pmid">14507218</pub-id></element-citation></ref><ref id="B10-marinedrugs-12-03399"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nieman</surname><given-names>J.A.</given-names></name><name><surname>Coleman</surname><given-names>J.E.</given-names></name><name><surname>Wallace</surname><given-names>D.J.</given-names></name><name><surname>Piers</surname><given-names>E.</given-names></name><name><surname>Lim</surname><given-names>L.Y.</given-names></name><name><surname>Roberge</surname><given-names>M.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues</article-title>
<source>J. Nat. Prod.</source>
<year>2003</year>
<volume>66</volume>
<fpage>183</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1021/np020375t</pub-id>
<pub-id pub-id-type="pmid">12608848</pub-id></element-citation></ref><ref id="B11-marinedrugs-12-03399"><label>11.</label><element-citation publication-type="patent">
<person-group person-group-type="author"><name><surname>Kowalczyk</surname><given-names>J.J.</given-names></name><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>Schiller</surname><given-names>S.</given-names></name><name><surname>Seletsky</surname><given-names>B.M.</given-names></name><name><surname>Spyvee</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name></person-group>
<article-title>Hemiasterlin Derivatives and Uses Thereof</article-title>
<source>US Patent</source>
<patent>US7,064,211B2</patent>
<day>20</day>
<month>6</month>
<year>2006</year>
</element-citation></ref><ref id="B12-marinedrugs-12-03399"><label>12.</label><element-citation publication-type="patent">
<person-group person-group-type="author"><name><surname>Kowalczyk</surname><given-names>J.J.</given-names></name><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>Schiller</surname><given-names>S.</given-names></name><name><surname>Seletsky</surname><given-names>B.M.</given-names></name><name><surname>Spyvee</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name></person-group>
<article-title>Hemiasterlin Derivatives and Uses Thereof</article-title>
<source>US Patent</source>
<patent>US7,192,972B2</patent>
<day>20</day>
<month>3</month>
<year>2007</year>
</element-citation></ref><ref id="B13-marinedrugs-12-03399"><label>13.</label><element-citation publication-type="patent">
<person-group person-group-type="author"><name><surname>Campagna</surname><given-names>S.A.</given-names></name><name><surname>Fang</surname><given-names>F.G.</given-names></name><name><surname>Kowalczyk</surname><given-names>J.J.</given-names></name><name><surname>Schiller</surname><given-names>S.</given-names></name><name><surname>Seletsky</surname><given-names>B.M.</given-names></name><name><surname>Spyvee</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name></person-group>
<article-title>Hemiasterlin Derivatives and Uses Thereof</article-title>
<source>US Patent</source>
<patent>US7,585,976B2</patent>
<day>8</day>
<month>9</month>
<year>2009</year>
</element-citation></ref><ref id="B14-marinedrugs-12-03399"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group>
<article-title>Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials</article-title>
<source>J. Nat. Prod.</source>
<year>2004</year>
<volume>67</volume>
<fpage>1216</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1021/np040031y</pub-id>
<pub-id pub-id-type="pmid">15332835</pub-id></element-citation></ref><ref id="B15-marinedrugs-12-03399"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Molinski</surname><given-names>T.F.</given-names></name><name><surname>Dalisay</surname><given-names>D.S.</given-names></name><name><surname>Lievens</surname><given-names>S.L.</given-names></name><name><surname>Saludes</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Drug development from marine natural products</article-title>
<source>Nat. Rev. Drug Discov.</source>
<year>2009</year>
<volume>8</volume>
<fpage>69</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1038/nrd2487</pub-id>
<pub-id pub-id-type="pmid">19096380</pub-id></element-citation></ref><ref id="B16-marinedrugs-12-03399"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>TenDyke</surname><given-names>K.</given-names></name><name><surname>Towle</surname><given-names>M.J.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Marsh</surname><given-names>J.P.</given-names></name><name><surname>Schiller</surname><given-names>S.E.R.</given-names></name><name><surname>Spyvee</surname><given-names>M.R.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Seletsky</surname><given-names>B.M.</given-names></name><etal/></person-group>
<article-title>Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin</article-title>
<source>Mol. Cancer Ther.</source>
<year>2009</year>
<volume>8</volume>
<fpage>2852</fpage>
<lpage>2860</lpage>
<pub-id pub-id-type="doi">10.1158/1535-7163.MCT-09-0301</pub-id>
<pub-id pub-id-type="pmid">19825803</pub-id></element-citation></ref><ref id="B17-marinedrugs-12-03399"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lima</surname><given-names>C.M.R.</given-names></name><name><surname>Bayraktar</surname><given-names>S.</given-names></name><name><surname>MacIntyre</surname><given-names>J.</given-names></name><name><surname>Raez</surname><given-names>L.</given-names></name><name><surname>Flores</surname><given-names>A.M.</given-names></name><name><surname>Ferrell</surname><given-names>A.</given-names></name><name><surname>Rubin</surname><given-names>E.H.</given-names></name><name><surname>Poplin</surname><given-names>E.A.</given-names></name><name><surname>Tan</surname><given-names>A.R.</given-names></name><name><surname>Lucarelli</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors</article-title>
<source>Cancer</source>
<year>2012</year>
<volume>118</volume>
<fpage>4262</fpage>
<lpage>4270</lpage>
<pub-id pub-id-type="doi">10.1002/cncr.27428</pub-id>
<pub-id pub-id-type="pmid">22294459</pub-id></element-citation></ref><ref id="B18-marinedrugs-12-03399"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camp</surname><given-names>D.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Campitelli</surname><given-names>M.</given-names></name><name><surname>Ebdon</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Drug-like properties: Guiding principles for the design of natural product libraries</article-title>
<source>J. Nat. Prod.</source>
<year>2012</year>
<volume>75</volume>
<fpage>72</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1021/np200687v</pub-id>
<pub-id pub-id-type="pmid">22204643</pub-id></element-citation></ref><ref id="B19-marinedrugs-12-03399"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silva</surname><given-names>E.D.D.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><name><surname>Allen</surname><given-names>T.M.</given-names></name></person-group>
<article-title>Geodiamolide C to F, new cytotoxic cyclodepsipeptides from the marine sponge <italic>Pseudodaxinyssa</italic> sp</article-title>
<source>Tetrahedron Lett.</source>
<year>1990</year>
<volume>31</volume>
<fpage>489</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/0040-4039(90)87015-R</pub-id>
</element-citation></ref><ref id="B20-marinedrugs-12-03399"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coleman</surname><given-names>J.E.</given-names></name><name><surname>Soest</surname><given-names>R.V.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group>
<article-title>New geodiamolides from the sponge <italic>Cymbastela</italic> sp. collected in Papua New Guinea</article-title>
<source>J. Nat. Prod.</source>
<year>1999</year>
<volume>62</volume>
<fpage>1137</fpage>
<lpage>1141</lpage>
<pub-id pub-id-type="doi">10.1021/np990155o</pub-id>
<pub-id pub-id-type="pmid">10479320</pub-id></element-citation></ref><ref id="B21-marinedrugs-12-03399"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Couperus</surname><given-names>P.A.</given-names></name><name><surname>Clague</surname><given-names>A.D.H.</given-names></name><name><surname>van Dongen</surname><given-names>J.P.C.M.</given-names></name></person-group>
<article-title>13C Chemical shifts of some model olefins</article-title>
<source>Org. Magn. Reson.</source>
<year>1976</year>
<volume>8</volume>
<fpage>426</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="doi">10.1002/mrc.1270080807</pub-id>
</element-citation></ref><ref id="B22-marinedrugs-12-03399"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kashman</surname><given-names>Y.</given-names></name><name><surname>Groweiss</surname><given-names>A.</given-names></name></person-group>
<article-title>New diterpenoids from the soft corals <italic>Xenia macrospiculata</italic> and <italic>Xenia obscuronata</italic></article-title>
<source>J. Org. Chem.</source>
<year>1980</year>
<volume>45</volume>
<fpage>3841</fpage>
<lpage>3824</lpage>
</element-citation></ref><ref id="B23-marinedrugs-12-03399"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graber</surname><given-names>M.A.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group>
<article-title>Kalkipyrone, a toxic &#x003b3;-pyrone from an assemblage of the marine cyanobacteria <italic>Lyngbya</italic>
<italic>majuscula</italic> and <italic>Tolypothrix</italic> sp</article-title>
<source>J. Nat. Prod.</source>
<year>1998</year>
<volume>61</volume>
<fpage>677</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="doi">10.1021/np970539j</pub-id>
<pub-id pub-id-type="pmid">9599278</pub-id></element-citation></ref><ref id="B24-marinedrugs-12-03399"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Masuno</surname><given-names>M.N.</given-names></name><name><surname>MacMillan</surname><given-names>J.B.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name></person-group>
<article-title>Enantioselective total synthesis of (+)-milnamide A and evidence of its autoxidation to (+)-milnamide D</article-title>
<source>Angew. Chem. Int. Ed.</source>
<year>2004</year>
<volume>43</volume>
<fpage>5951</fpage>
<lpage>5954</lpage>
</element-citation></ref><ref id="B25-marinedrugs-12-03399"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marfey</surname><given-names>P.</given-names></name></person-group>
<article-title>Determination of <sc>d</sc>-Amino Acids. II. Use of a Bifunctional Reagent, 1,5-difluoro-2,4-dinitrobenzene</article-title>
<source>Carlsberg Res. Commun.</source>
<year>1984</year>
<volume>49</volume>
<fpage>591</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="doi">10.1007/BF02908688</pub-id>
</element-citation></ref><ref id="B26-marinedrugs-12-03399"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kochhar</surname><given-names>S.</given-names></name><name><surname>Christen</surname><given-names>P.</given-names></name></person-group>
<article-title>Amino acid analysis by high-performance liquid chromatography after derivatization with 1-fluoro-2,4-dinitrophenyl-5-<sc>l</sc>-alanine amide</article-title>
<source>Anal. Biochem.</source>
<year>1989</year>
<volume>178</volume>
<fpage>17</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/0003-2697(89)90348-5</pub-id>
<pub-id pub-id-type="pmid">2729569</pub-id></element-citation></ref><ref id="B27-marinedrugs-12-03399"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tran</surname><given-names>T.D.</given-names></name><name><surname>Pham</surname><given-names>N.B.</given-names></name><name><surname>Fechner</surname><given-names>G.</given-names></name><name><surname>Zencak</surname><given-names>D.</given-names></name><name><surname>Vu</surname><given-names>H.T.</given-names></name><name><surname>Hooper</surname><given-names>J.N. A.</given-names></name><name><surname>Quinn</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Cytotoxic cyclic depsipeptides from the Australian marine sponge <italic>Neamphius huxleyi</italic></article-title>
<source>J. Nat. Prod.</source>
<year>2012</year>
<volume>75</volume>
<fpage>2200</fpage>
<lpage>2208</lpage>
<pub-id pub-id-type="doi">10.1021/np3006474</pub-id>
<pub-id pub-id-type="pmid">23215348</pub-id></element-citation></ref></ref-list></back></article>